Grace C Lee1,2, T Clark Gamblin3, Zhi Ven Fong1,2, Cristina R Ferrone1,2, Lipika Goyal2,4, Keith D Lillemoe1,2, Lawrence S Blaszkowsky2,4, Kenneth K Tanabe1,2, Motaz Qadan5,6,7. 1. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. 2. Newton Wellesley Hospital, Newton, MA, USA. 3. Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. 4. Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. 5. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. MQADAN@mgh.harvard.edu. 6. Newton Wellesley Hospital, Newton, MA, USA. MQADAN@mgh.harvard.edu. 7. Surgical Oncology Associates, Massachusetts General Hospital, Boston, MA, USA. MQADAN@mgh.harvard.edu.
Abstract
BACKGROUND: Many studies have demonstrated associations between surgical resections at academic centers and improved outcomes, particularly for complex operations. However, few studies have examined this relationship in intrahepatic cholangiocarcinoma (ICC). The hypothesis of this study was that facility type is associated with improved postoperative outcomes and survival for patients with ICC who undergo resection. METHODS: Patients with stages 1 to 3 ICC who underwent hepatectomy were identified using the National Cancer Database (NCDB) (2004-2014). Facilities were categorized as academic or community centers per Commission on Cancer designations. High-volume hospitals were those that performed 11 or more hepatectomies per year. Multilevel logistic mixed-effects models to identify predictors of outcomes and parametric survival-time models were used to determine overall survival (OS). RESULTS: The study identified 2256 patients. Of these patients, 423 (18.8%) were treated at community centers, and 1833 (81.3%) were treated at academic centers. Nearly all high-volume centers were academic facilities (98.5% academic vs. 1.5% community centers), whereas low-volume centers were mixed (65.5% academic vs. 34.5% community centers) (p < 0.001). Surgery performed at an academic center was an independent predictor of decreased positive margins (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.51-0.98; p = 0.04), a lower 90-day mortality rate (OR, 0.62; 95% CI, 0.39-0.97; p = 0.03), and improved OS (hazard ratio [HR], 0.78; 95% CI, 0.63-0.96; p = 0.02). Facility hepatectomy volume was not independently associated with any short- or long-term outcomes. CONCLUSIONS: Treatment at an academic center is associated with fewer positive resection margins, a decreased 90-day mortality rate, and improved OS for patients who undergo ICC resection. Facility surgical volume was not shown to be significantly associated with any postoperative outcomes after adjustment for patient and disease characteristics.
BACKGROUND: Many studies have demonstrated associations between surgical resections at academic centers and improved outcomes, particularly for complex operations. However, few studies have examined this relationship in intrahepatic cholangiocarcinoma (ICC). The hypothesis of this study was that facility type is associated with improved postoperative outcomes and survival for patients with ICC who undergo resection. METHODS:Patients with stages 1 to 3 ICC who underwent hepatectomy were identified using the National Cancer Database (NCDB) (2004-2014). Facilities were categorized as academic or community centers per Commission on Cancer designations. High-volume hospitals were those that performed 11 or more hepatectomies per year. Multilevel logistic mixed-effects models to identify predictors of outcomes and parametric survival-time models were used to determine overall survival (OS). RESULTS: The study identified 2256 patients. Of these patients, 423 (18.8%) were treated at community centers, and 1833 (81.3%) were treated at academic centers. Nearly all high-volume centers were academic facilities (98.5% academic vs. 1.5% community centers), whereas low-volume centers were mixed (65.5% academic vs. 34.5% community centers) (p < 0.001). Surgery performed at an academic center was an independent predictor of decreased positive margins (odds ratio [OR], 0.71; 95% confidence interval [CI], 0.51-0.98; p = 0.04), a lower 90-day mortality rate (OR, 0.62; 95% CI, 0.39-0.97; p = 0.03), and improved OS (hazard ratio [HR], 0.78; 95% CI, 0.63-0.96; p = 0.02). Facility hepatectomy volume was not independently associated with any short- or long-term outcomes. CONCLUSIONS: Treatment at an academic center is associated with fewer positive resection margins, a decreased 90-day mortality rate, and improved OS for patients who undergo ICC resection. Facility surgical volume was not shown to be significantly associated with any postoperative outcomes after adjustment for patient and disease characteristics.
Authors: John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg Journal: N Engl J Med Date: 2002-04-11 Impact factor: 91.245
Authors: Zhi Ven Fong; Andrew P Loehrer; Carlos Fernández-Del Castillo; Yanik J Bababekov; Ginger Jin; Cristina R Ferrone; Andrew L Warshaw; Lara N Traeger; Matthew M Hutter; Keith D Lillemoe; David C Chang Journal: Surgery Date: 2017-05-11 Impact factor: 3.982
Authors: John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores Journal: J Hepatol Date: 2014-03-27 Impact factor: 25.083
Authors: Malcolm H Squires; Jordan M Cloyd; Mary Dillhoff; Carl Schmidt; Timothy M Pawlik Journal: Expert Rev Gastroenterol Hepatol Date: 2018-06-27 Impact factor: 3.869
Authors: Gaya Spolverato; Alessandro Vitale; Alessandro Cucchetti; Irinel Popescu; Hugo P Marques; Luca Aldrighetti; T Clark Gamblin; Shishir K Maithel; Charbel Sandroussi; Todd W Bauer; Feng Shen; George A Poultsides; J Wallis Marsh; Timothy M Pawlik Journal: Cancer Date: 2015-08-11 Impact factor: 6.860
Authors: Mohamedraed Elshami; Jonathan J Hue; Fasih Ali Ahmed; Hanna Kakish; Richard S Hoehn; Luke D Rothermel; Jeffrey M Hardacre; John B Ammori; Jordan M Winter; Lee M Ocuin Journal: J Gastrointest Surg Date: 2022-09-22 Impact factor: 3.267
Authors: T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica Journal: Curr Probl Surg Date: 2020-06-30 Impact factor: 1.909
Authors: May T Cho; Sepideh Gholami; Dorina Gui; Sooraj L Tejaswi; Ghaneh Fananapazir; Nadine Abi-Jaoudeh; Zeljka Jutric; Jason B Samarasena; Xiaodong Li; Jennifer B Valerin; Jacob Mercer; Farshid Dayyani Journal: Cancers (Basel) Date: 2022-01-13 Impact factor: 6.639